Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 792

1.

Long-term Morbidity of Testicular Cancer Treatment.

Fung C, Fossa SD, Williams A, Travis LB.

Urol Clin North Am. 2015 Aug;42(3):393-408. doi: 10.1016/j.ucl.2015.05.002. Epub 2015 Jun 10. Review.

PMID:
26216826
2.

"Natural course" of disease in patients with metastatic castrate-resistant prostate cancer: Survival and prognostic factors without life-prolonging treatment.

Löffeler S, Weedon-Fekjaer H, Wang-Hansen MS, Sebakk K, Hamre H, Haug ES, Fosså SD.

Scand J Urol. 2015 Jul 3:1-6. [Epub ahead of print]

PMID:
26139461
3.

A comparative study of erectile function and use of erectile aids in high-risk prostate cancer patients after robot-assisted laparoscopic prostatectomy.

Østby-Deglum M, Brennhovd B, Axcrona K, Fosså SD, Dahl AA.

Scand J Urol. 2015 Jun 26:1-7. [Epub ahead of print]

PMID:
26116048
4.

Palliative pelvic radiotherapy for symptomatic incurable prostate cancer - A prospective multicenter study.

Cameron MG, Kersten C, Vistad I, van Helvoirt R, Weyde K, Undseth C, Mjaaland I, Skovlund E, Fosså SD, Guren MG.

Radiother Oncol. 2015 Jun;115(3):314-20. doi: 10.1016/j.radonc.2015.05.021. Epub 2015 Jun 16.

5.

Effects of strength training on body composition, physical functioning, and quality of life in prostate cancer patients during androgen deprivation therapy.

Nilsen TS, Raastad T, Skovlund E, Courneya KS, Langberg CW, Lilleby W, Fosså SD, Thorsen L.

Acta Oncol. 2015 Apr 30:1-9. [Epub ahead of print]

PMID:
25927504
6.

Two new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor.

Kristiansen W, Karlsson R, Rounge TB, Whitington T, Andreassen BK, Magnusson PK, Fosså SD, Adami HO, Turnbull C, Haugen TB, Grotmol T, Wiklund F.

Hum Mol Genet. 2015 Jul 15;24(14):4138-46. doi: 10.1093/hmg/ddv129. Epub 2015 Apr 15.

PMID:
25877299
7.

Chronic fatigue is prevalent and associated with hormonal dysfunction in long-term non-Hodgkin lymphoma survivors treated with radiotherapy to the head and neck region.

Seland M, Holte H, Bjøro T, Schreiner T, Bollerslev J, Loge JH, Fosså SD, Kiserud CE.

Leuk Lymphoma. 2015 May 18:1-9. [Epub ahead of print]

PMID:
25827172
8.

Long-term platinum retention after platinum-based chemotherapy in testicular cancer survivors: a 20-year follow-up study.

Hjelle LV, Gundersen PO, Oldenburg J, Brydøy M, Tandstad T, Wilsgaard T, Fosså SD, Bremnes RM, Haugnes HS.

Anticancer Res. 2015 Mar;35(3):1619-25.

PMID:
25750319
9.

Hormonal dysfunction is frequent in cancer survivors treated with radiotherapy to the head and neck region.

Seland M, Bjøro T, Furre T, Schreiner T, Bollerslev J, Fosså SD, Loge JH, Holte H, Kiserud CE.

J Cancer Surviv. 2015 Mar 7. [Epub ahead of print]

PMID:
25750158
10.

Exome sequencing of bilateral testicular germ cell tumors suggests independent development lineages.

Brabrand S, Johannessen B, Axcrona U, Kraggerud SM, Berg KG, Bakken AC, Bruun J, Fosså SD, Lothe RA, Lehne G, Skotheim RI.

Neoplasia. 2015 Feb;17(2):167-74. doi: 10.1016/j.neo.2014.12.005.

11.

Providing information about late effects after childhood cancer: lymphoma survivors' preferences for what, how and when.

Lie HC, Loge JH, Fosså SD, Hamre HM, Hess SL, Mellblom AV, Ruud E, Finset A.

Patient Educ Couns. 2015 May;98(5):604-11. doi: 10.1016/j.pec.2015.01.016. Epub 2015 Jan 31.

PMID:
25704291
12.

Coronary calcium score in 12-year breast cancer survivors after adjuvant radiotherapy with low to moderate heart exposure - Relationship to cardiac radiation dose and cardiovascular risk factors.

Tjessem KH, Bosse G, Fosså K, Reinertsen KV, Fosså SD, Johansen S, Fosså A.

Radiother Oncol. 2015 Mar;114(3):328-34. doi: 10.1016/j.radonc.2015.01.006. Epub 2015 Jan 16.

PMID:
25600105
13.

Changes in prostate-specific antigen, markers of bone metabolism and bone scans after treatment with radium-223.

Nome R, Hernes E, Bogsrud TV, Bjøro T, Fosså SD.

Scand J Urol. 2015 Jun;49(3):211-7. doi: 10.3109/21681805.2014.982169. Epub 2014 Dec 17.

PMID:
25515952
14.

Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the "cisplatin era".

Solheim O, Tropé CG, Rokkones E, Kærn J, Paulsen T, Salvesen HB, Hagen B, Vereide AB, Fosså SD.

Gynecol Oncol. 2015 Feb;136(2):224-9. doi: 10.1016/j.ygyno.2014.12.010. Epub 2014 Dec 12.

PMID:
25511159
15.

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.

Sternberg CN, Skoneczna I, Kerst JM, Albers P, Fossa SD, Agerbaek M, Dumez H, de Santis M, Théodore C, Leahy MG, Chester JD, Verbaeys A, Daugaard G, Wood L, Witjes JA, de Wit R, Geoffrois L, Sengelov L, Thalmann G, Charpentier D, Rolland F, Mignot L, Sundar S, Symonds P, Graham J, Joly F, Marreaud S, Collette L, Sylvester R; European Organisation for Research and Treatment of Cancer Genito-Urinary Cancers Group; Groupe d'Etude des Tumeurs Urogénitales; National Cancer Research Institute Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; German Association of Urologic Oncology.

Lancet Oncol. 2015 Jan;16(1):76-86. doi: 10.1016/S1470-2045(14)71160-X. Epub 2014 Dec 11.

PMID:
25498218
16.

Severe postprostatectomy incontinence: Is there an association between preoperative urodynamic findings and outcome of incontinence surgery?

Holm HV, Fosså SD, Hedlund H, Schultz A, Dahl AA.

Scand J Urol. 2015 Jun;49(3):250-9. doi: 10.3109/21681805.2014.980845. Epub 2014 Nov 27.

PMID:
25428752
17.

Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.

Oldenburg J, Aparicio J, Beyer J, Cohn-Cedermark G, Cullen M, Gilligan T, De Giorgi U, De Santis M, de Wit R, Fosså SD, Germà-Lluch JR, Gillessen S, Haugnes HS, Honecker F, Horwich A, Lorch A, Ondruš D, Rosti G, Stephenson AJ, Tandstad T; On behalf of: SWENOTECA (Swedish Norwegian Testicular Cancer group), the Italian Germ Cell Cancer Group (IGG), Spanish Germ Cell Cancer Group (SGCCG).

Ann Oncol. 2015 May;26(5):833-8. doi: 10.1093/annonc/mdu514. Epub 2014 Nov 6. Review.

PMID:
25378299
18.

Increased stomach cancer risk following radiotherapy for testicular cancer.

Hauptmann M, Fossa SD, Stovall M, van Leeuwen FE, Johannesen TB, Rajaraman P, Gilbert ES, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Travis LB, Morton LM.

Br J Cancer. 2015 Jan 6;112(1):44-51. doi: 10.1038/bjc.2014.552. Epub 2014 Nov 4.

PMID:
25349972
19.

Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones.

Aschim EL, Oldenburg J, Kristiansen W, Giwercman A, Witczak O, Fosså SD, Haugen TB.

Hum Reprod. 2014 Dec;29(12):2844-51. doi: 10.1093/humrep/deu274. Epub 2014 Oct 21.

PMID:
25336703
20.

Circulating tumor cells in patients with metastatic castration resistant prostate cancer: exploratory findings at a tertiary referral hospital.

Fosså SD, Hess SL, Paus E, Borgen E.

Res Rep Urol. 2014 Sep 27;6:121-6. doi: 10.2147/RRU.S68477. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk